Table 3. Logistic regression analysis on the effect of predominant enterovirus serotypes in severe HFMD.
Variable | Unadjusted | Adjusted | ||||
OR | 95%CI | P | OR | 95%CI | P | |
Age, months | ||||||
≤12 | 4.26 | 2.77–6.54 | <0.001 | 4.25 | 2.72–6.64 | <0.001 |
12∼24 | 2.05 | 1.41–2.99 | <0.001 | 2.08 | 1.41–3.07 | <0.001 |
24∼36 | 1.78 | 1.20–2.65 | 0.004 | 1.85 | 1.22–2.79 | 0.004 |
36∼48 | 2.22 | 1.45–3.39 | <0.001 | 2.16 | 1.39–3.36 | <0.001 |
>48 | 1.0 | 1.0 | ||||
Sex, male/female | 0.87 | 0.71–1.06 | 0.168 | 0.94 | 0.75–1.17 | 0.556 |
Enterovirus | ||||||
EV-71 | 4.58 | 2.97–7.07 | <0.001 | 4.81 | 3.07–7.53 | <0.001 |
CV-A16 | 1.37 | 0.86–2.19 | 0.182 | 1.51 | 0.94–2.45 | 0.092 |
CV-A10 | 2.29 | 1.24–4.22 | 0.008 | 2.66 | 1.40–5.06 | 0.003 |
CV-A6 | 0.88 | 0.37–2.11 | 0.776 | 1.20 | 0.48–3.02 | 0.700 |